Evidence map›Paper›PMID 35785155›Full record

ArticleFrontiers in oncology2022

Development and Validation of Prognostic Model for Lung Adenocarcinoma Patients Based on m6A Methylation Related Transcriptomics.

Huijun Li, Song-Bai Liu, Junjie Shen, Lu Bai, Xinyan Zhang, Jianping Cao, Nengjun Yi, Ke Lu, Zaixiang Tang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Huijun LiDepartment of Biostatistics, School of Public Health, Medical College of Soochow University, Suzhou, China.
Song-Bai LiuDepartment of Medical Biotechnology, Suzhou Key Laboratory of Medical Biotechnology, Suzhou Vocational Health College, Suzhou, China.
Junjie ShenDepartment of Biostatistics, School of Public Health, Medical College of Soochow University, Suzhou, China.
Lu BaiDepartment of Biostatistics, School of Public Health, Medical College of Soochow University, Suzhou, China.
Xinyan ZhangSchool of Data Science and Analytics, Kennesaw State University, Kennesaw, GA, United States.
Jianping CaoSchool of Radiation Medicine and Protection and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, China.
Nengjun YiDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, United States.
Ke LuDepartment of Orthopedics, Affiliated Kunshan Hospital of Jiangsu University, Suzhou, China.
Zaixiang TangDepartment of Biostatistics, School of Public Health, Medical College of Soochow University, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Existing studies suggest that m

Indexed as

drug prediction.immunotherapylung adenocarcinomam6Aprognostic model

Identifiers

PMID35785155
PMCPMC9243308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.